Obesity in China

From WikiMD's WELLNESSPEDIA


China, located in East Asia and Southeast Asia, had an adult obesity rate of 6.2% in 2016, ranking 169th globally. This is a significant health concern, as obesity is linked to a variety of serious health conditions, including heart disease, diabetes, and certain types of cancer.

Obesity in China[edit]

The obesity rate in China has been steadily increasing over the past few decades. This is largely due to changes in diet and lifestyle, with a shift towards more sedentary activities and consumption of high-calorie, processed foods. The Chinese government has implemented various initiatives to combat this growing health issue, including public health campaigns promoting physical activity and healthy eating.

Healthcare Facilities[edit]

There are several well-known healthcare facilities in China that offer weight loss programs and treatments. These include:

  • Shanghai East International Medical Center: This facility offers a comprehensive weight loss program that includes nutritional counseling, exercise therapy, and medical treatments.
  • Beijing United Family Hospital: This hospital provides a multidisciplinary approach to weight loss, with services including diet and nutrition counseling, physical therapy, and surgical options.
  • Guangzhou Elizabeth Women's Hospital: This hospital offers a specialized weight loss program for women, including nutritional counseling, exercise programs, and psychological support.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.